Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1984 1
1985 4
1986 4
1987 8
1989 6
1990 5
1991 6
1992 12
1993 13
1994 14
1995 12
1996 11
1997 13
1998 6
1999 23
2000 21
2001 25
2002 21
2003 37
2004 49
2005 71
2006 80
2007 100
2008 140
2009 163
2010 174
2011 210
2012 252
2013 301
2014 416
2015 407
2016 436
2017 537
2018 541
2019 629
2020 767
2021 845
2022 701
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

6,266 results
Results by year
Filters applied: . Clear all
Page 1
Expert consensus on the use of omalizumab in chronic urticaria in China.
Zhao Z, Cai T, Chen H, Chen L, Chen Y, Gao X, Gao X, Geng S, Guo Y, Hao F, Hao G, Hu Y, Jin H, Jin Z, Li C, Li H, Li J, Li Y, Liang Y, Liu G, Liu Q, Long H, Ma L, Shang Y, Song Y, Song Z, Su X, Sui H, Sun Q, Sun Y, Tang J, Tong X, Wang H, Wang G, Wang L, Wang S, Xiang L, Xiao T, Xie Z, Ye L, Yu Y, Zhang C, Zhang L, Zhang S, Zheng R, Zhi L, Zhou W, Zou Y, Maurer M. Zhao Z, et al. Among authors: ye l. World Allergy Organ J. 2021 Dec 5;14(11):100610. doi: 10.1016/j.waojou.2021.100610. eCollection 2021 Nov. World Allergy Organ J. 2021. PMID: 34934470 Free PMC article. Review.
Radical Reactions of Ynamides.
Tan TD, Wang ZS, Qian PC, Ye LW. Tan TD, et al. Among authors: ye lw. Small Methods. 2021 Mar;5(3):e2000673. doi: 10.1002/smtd.202000673. Epub 2020 Sep 29. Small Methods. 2021. PMID: 34927818 Review.
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.
Halperin SA, Ye L, MacKinnon-Cameron D, Smith B, Cahn PE, Ruiz-Palacios GM, Ikram A, Lanas F, Lourdes Guerrero M, Muñoz Navarro SR, Sued O, Lioznov DA, Dzutseva V, Parveen G, Zhu F, Leppan L, Langley JM, Barreto L, Gou J, Zhu T; CanSino COVID-19 Global Efficacy Study Group. Halperin SA, et al. Among authors: ye l. Lancet. 2022 Jan 15;399(10321):237-248. doi: 10.1016/S0140-6736(21)02753-7. Epub 2021 Dec 23. Lancet. 2022. PMID: 34953526 Free PMC article. Clinical Trial.
High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails.
Shy BR, Vykunta VS, Ha A, Talbot A, Roth TL, Nguyen DN, Pfeifer WG, Chen YY, Blaeschke F, Shifrut E, Vedova S, Mamedov MR, Chung JJ, Li H, Yu R, Wu D, Wolf J, Martin TG, Castro CE, Ye L, Esensten JH, Eyquem J, Marson A. Shy BR, et al. Among authors: ye l. Nat Biotechnol. 2022 Aug 25. doi: 10.1038/s41587-022-01418-8. Online ahead of print. Nat Biotechnol. 2022. PMID: 36008610
Design of a Genetically Programmed Biomimetic Lipase Nanoreactor.
Wang Q, Xiao Y, Zhu J, Ye L, Zhang L, Wang L, Wang X, Pang H, Li J, Yuan S, Niu L, Chen M, Yan Y, Xu L, Yan J. Wang Q, et al. Among authors: ye l. ACS Appl Bio Mater. 2021 Apr 19;4(4):3518-3523. doi: 10.1021/acsabm.1c00048. Epub 2021 Mar 24. ACS Appl Bio Mater. 2021. PMID: 35014436
6,266 results